Related Experiment Video
Updated: Jan 11, 2026

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
Advanced polyelectrolyte complexes for ultrafast hemostasis and blood superabsorption.
Sajjad Fanaee1, Alireza Zabihihesari2, Tianqin Ning3
1School of Biomedical Engineering, Dalhousie University, Halifax, NS B3H 4R2, Canada; Department of Biomaterials & Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, Halifax, NS B3H 4R2, Canada.
New hemostatic sponges control bleeding by releasing polyphosphates (PP) through tunable electrostatic interactions. These superabsorbent devices significantly reduce clotting time and absorb large fluid volumes, improving trauma survival rates.
Area of Science:
- Biomaterials Science
- Hemostasis Research
- Polymer Chemistry
Background:
- Hemorrhage is a major cause of trauma mortality.
- Current hemostatic devices aim to control bleeding but have limitations.
- Polyphosphates (PP) accelerate blood clotting but require controlled delivery.
Purpose of the Study:
- To develop a superabsorbent hemostatic device with time-controlled release of procoagulant polyphosphates (PP).
- To investigate the mechanism of PP binding and release from modified chitosan scaffolds.
- To evaluate the in vitro and in vivo efficacy of the hemostatic sponges in controlling blood loss.
Main Methods:
- Fabrication of modified chitosan sponge scaffolds with tunable electrostatic properties.
- Characterization of polyphosphate (PP) binding and release kinetics using electrostatic interactions.
- In vitro assessment of blood clotting time under static and dynamic conditions.
- In vivo evaluation of hemostatic efficacy using a rat hepatic hemorrhage model.
Main Results:
- The hemostatic sponges demonstrated controlled release of PP via competing electrostatic interactions.
- Blood clotting time was reduced by up to 75% in vitro and in vivo.
- The sponges exhibited superabsorbent properties, absorbing up to 25 times their dry mass in fluid within 8 hours.
- Consistent efficacy was observed across in vitro and in vivo studies.
Conclusions:
- A novel polyelectrolyte complex-based hemostatic sponge effectively controls bleeding.
- Tunable electrostatic interactions enable time-controlled release of polyphosphates for enhanced hemostasis.
- The superabsorbent and rapid clotting properties make these sponges suitable for managing various bleeding conditions.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

